Dihydropyridines
(DHPs) generally have little effect on wholecell calcium currents of neurons, even at concentrations far higher than those effective on muscle. Either neuronal calcium currents are much less sensitive to DHPs, or only a small proportion of the current is DHP-sensitive. We find that DHP agonists and antagonists act at low concentration on calcium currents in frog sympathetic neurons but that the effects are small even at optimal concentrations.
The halfmaximal dose (EC,,) of the agonist Bay K 8844 is -50 nM, and the effect of Bay K 8644 is blocked by 50% at -300 nM nifedipine, from a holding potential of -80 mV. Nifedipine is more effective from a holding potential of -50 mV. These results suggest the presence of an L-type calcium current, with DHP sensitivity similar to L-currents in cardiac muscle. The predominant (>90%) calcium current in frog sympathetic neurons is a DHP-resistant N-type current. However, high concentrations of DHPs (10 CLM) partially block N-type calcium current, as well as voltage-dependent sodium and potassium currents.
Calcium currents are necessary for a wide variety of cellular functions, ranging from muscle contraction to neurotransmitter release. The time scale of these processes varies from hundreds to tenths of milliseconds. It is perhaps not surprising that a variety of calcium channels would evolve to serve these diverse functions. The proposal (Nowycky et al., 1985) of a novel (Ntype) calcium current, specialized for the extremely rapid process of transmitter release from neurons (Perney et al., 1986; Hirning et al., 1988) , thus received wide initial acceptance. However, the N-current cannot be easily separated from the classic L-current in whole-cell recordings, so some have questioned the existence of 2 distinct currents (Swandulla and Armstrong, 1988) . At the single-channel level, it appears clear that both L-and N-type channels exist in sympathetic neurons (Himing et al., 1988; Lipscombe et al., 1988) . Recently, Jones and Marks (1989a, b) and Plummer et al. (1989) proposed that the whole-cell current is primarily N-type but that dihydropyridine (DHP) agonists reveal a cryptic L-current. With this interpretation, the N-current of sympathetic neurons differs from that originally described in sensory neurons (Fox et al., 1987a, b) in showing Received Dec. 18, 1989; revised Feb. 7, 1990; accepted Feb. 13, 1990. This work was supported by National Institutes of Health Grant NS 2447 1 to S.W.J., and L.S.J. was supported by training grant HL 07653. We thank Theodore N. Marks and Dr. Keith S. Ehnslie for helpful comments on the manuscript. We also thank Drs. A. Scriabine, D. Roemer, and E. Rissi for providing samples of DHPs.
Correspondence should be addressed to Stephen W. Jones at the above address. Copyright 0 1990 Society for Neuroscience 0270-6474/90/072261-07$03.00/O slow (7 -200 msec) and incomplete inactivation. Thus, the kinetics ofwhole-cell calcium currents do not readily distinguish L-and N-currents. In particular, the current remaining at the end of a -1 set depolarization cannot be identified as L-current (Aosaki and Kasai, 1989; Bean, 1989; Jones and Marks, 1989b; Plummer et al., 1989 ; see also Tsien et al., 1988) .
The actions of DHPs thus become critical for distinguishing these otherwise similar currents. In whole-cell recordings, the clearest evidence for the existence of the L-current is a slight potentiation by DHP agonists, most obvious in slow tail currents (Jones and Marks, 1989a; Plummer et al., 1989) . However, the definition of the L-current as a current potentiated by DHP agonists (Plummer et al., 1989) obviously begs the question of the contribution of the L-current under normal conditions. The use of DHP antagonists is problematic, as their action is strongly voltage dependent (Bean, 1984; Sanguinetti and Kass, 1984) . This paper demonstrates that the neuronal L-current is similar in DHP sensitivity to the predominant (L-type) calcium current of cardiac muscle. This supports the qualitative distinction between DHP-resistant N-current and highly DHP-sensitive L-current. However, extremely high concentrations of DHPs have nonspecific blocking actions on other voltagedependent currents. These results also support previous conclusions that the L-current contributes little (< 10%) to wholecell calcium currents in sympathetic neurons (Jones and Marks, 1989a; Plummer et al., 1989) .
A preliminary report of some of these results has appeared (Jones and Jacobs, 1989) .
Materials and Methods
Currents were recorded in the whole-cell patch-clamp configuration using an Axopatch 2A amplifier (Axon Instruments, Burlingame, CA) from isolated frog sympathetic neurons (Jones and Marks, 1989a) . Bullfrogs (Rana catesbeiana) were used for most experiments, but Ram pipiens were occasionally substituted. For experiments on calcium currents, electrodes contained 76.5 mM N-methyl-D-ghicamine (NMG) chloride, 2.5 mM HEPES, 10 mM EGTA or BAPTA, 5 mM Tris ATP, and 4 mM MgCl,, titrated to pH 7.2 with NMG base; the extracellular solution was 117.5 mM NMG'Cl, 2.5 mM NMG'HEPES, and 2 rnr.4 BaCl, (pH 7.2). For sodium and potassium currents, electrodes contained 100 mM KCl, 2.5 mM NaHEPES, 4 mM MgCl,, 5 mM Na,ATP, and 1 mM K,EGTA, titrated to pH 7.2 with KOH; the extracellular solution was 115 mM NaCl, 2.5 mM KCl, 2.5 mM NaHEPES, and 2 mM MnCl, (pH 7.2).
Bay were used to analyze and display data. Data were leak subtracted using scaled and averaged currents from hyperpolarizing voltage steps and digitally filtered at 3-4 kHz or as noted. The holding potential was -80 mV unless otherwise noted.
Results

Agonists
The DHP calcium channel agonist Bay K 8644 has little effect on the peak calcium current but markedly enhances the current at negative membrane potentials ( Fig. 1 ). This is apparent as an increase in current upon depolarizing steps directly to -40 mV, which under control conditions elicit a barely detectable current. In addition, a slow component appears in tail currents following repolarization to -40 mV from more depolarized voltages ( Fig. 1, arrows) . The effect of Bay K 8644 is dosedependent and slowly reversible ( Fig. 2A ). High concentrations of Bay K 8644 actually decrease the peak calcium current ( Fig. 2A) , which could be due to a partial antagonist action (Sanguinetti et al., 1986) . Bay K 8644 contains 2 isomers, one of which is actually an antagonist (Kass, 1987) . However, the inhibitory effect is also seen with the "pure" DHP agonist isomer (+)202-79 1 (Fig. 2B ). Note particularly that the first application of 10 PM (+)202-791 had a complex effect on the peak current. Much later in the same cell, 10 PM (+)202-791 had a much smaller effect on the slow tail currents, suggesting that most of the DHP agonist-sensitive current had run down. The effect on peak current was then a monophasic in- . Currents were measured every 5 set during washin and washout of Bay K 8644, and less frequently otherwise. Increasing current is shown upwards. The peak current at -10 mV (0) and the tail current at 5-6 msec following repolarization from -10 to -40 mV (0) were measured. The "tail current" measurement includes both the steady-state current at -40 mV and any slowly deactivating tail current (see Fig. 1 ). Cell 88d29. B, Effect of (+)202-791, measured as for Bay K 8644, for concentrations in decreasing order, with the highest concentration applied again at the end ofthe experiment. The shorter horizontal bars mark points where control solution was washed through the flow system to remove any drug remaining in the tubing. Cell a9928.
hibition. It appears likely that the complex effect observed during the first application is a superposition of a slowly developing but rapidly reversible inhibition, and a rapidly developing but slowly reversible potentiation. This sequence of effects was observed in 2 other cells where 10 PM (+)202-79 1 was tested more than once. One explanation of this result is that the inhibition and the potentiation are of different currents, which run down at different rates. The activation kinetics of currents near 0 mV and the major rapid component of tail current at -40 mV appear unaffected by Bay K 8644 (Fig. 1) . The most sensitive measure of enhancement of calcium current by DHP agonists is the tail current 5-6 msec following repolarization to -40 mV, where the fast component was essentially complete but the slow component 1 10 100 1000
Bay K 8644, nM Figure 3 . Dose-response relations for Bay K 8644. The increase in tail currents at -40 mV, 5-6 msec following repolarization from -10 or 0 mV, was measured. To correct for rundown, each measurement was divided by the amplitude of the peak current prior to that application of Bay K 8644. As the maximal effect of Bay K 8644 varied from cell to cell (5-to 15-fold enhancement of the slow tail current), values were further normalized to that at 10 FM. Data are from 3 cells where all 4 concentrations were tested, plus 1 cell tested only at 0.1-10 FM.
Data are means + SEM. The smooth curve is drawn from the law of mass action with maximal effect 1.1 times that at 10 KM, with a halfmaximal effect at 50 nM.
was still largely present (Plummer et al., 1989) . That current could be increased severalfold by Bay K 8644 ( Fig. 2A) . The effect of Bay K 8644 on tail currents was usually apparent at 10 nM (Figs. 1, 2A) and was maximal at l-10 PM. Doseresponse relations (Fig. 3) indicate a half-maximal effect at -50 nM. Since the effect of Bay K 8644 is voltage-dependent (Sanguinetti et al., 1986) , the half-maximal effect might be different at other voltages. The shift of activation to more negative membrane potentials is reminiscent of Bay K 8644 effects on calcium currents of cardiac (Hess et al., 1984) and smooth muscle (Bean et al., 1986; Caffrey et al., 1986) . However, the relative insensitivity of peak current to Bay K 8644 (Figs. 1,2) contrasts with the severalfold enhancement observed in muscle. The simplest explanation of these results is that Bay K 8644 acts with high potency on a neuronal calcium current, but only a small fraction of the total current is enhanced by DHP agonists.
If the current sensitive to DHP agonists is truly an L-current, it should be blocked by DHP antagonists, in a voltage-dependent manner. The small maximal effect of DHP antagonists on the control current (Jones and Marks, 1989a; Plummer et al., 1989) makes it difficult to examine their potency directly (Fig. 4) . But the current potentiated by DHP agonists is large enough for blockade by DHP antagonists to be studied (Fig. 5 ). In the cell illustrated in Figure 5 , nifedipine reversibly inhibited the effect of Bay K 8644. At 100 nM, nifedipine had a clear effect, and at 1 PM reduced the slow tail currents essentially to control levels. Preliminary experiments indicate that other DHP antagonists [nimodipine, nisoldipine, and (-)202-79 l] have effects qualitatively similar to nifedipine, but the effect of nifedipine appears to be most readily reversible. Dose-response relations for 9 cells (each tested at 2 nifedipine concentrations, as in Fig. 5A ) are shown in Figure 6 (solid symbols and line). The DHP agonistenhanced current of frog sympathetic neurons is clearly sensitive Figure 6 . Dose-response relations for nifedipine. Data, from the protocol of Figure 5A , are normalized such that 0 equals the average of tail currents before and after Bay K 8644, and 1 equals the average of tail currents in Bay K 8644 before and after nifedipine (B). Five cells were tested at 100 and 1000 nM nifedipine, and 4 cells at 50 and 500 nM. The so/id curve is drawn from the law of mass action, fit by eye to an EC,, of 300 nM. The effect of nifedipine on the peak current (in the absence of Bay K 8644) is also shown (O), for 4-5 cells at each concentration. The dashed line is drawn for an EC,, of 30 PM.
to nifedipine at < 1 PM, even from a holding potential of -80 mV, with an EC,, of -300 nM. Nifedipine is much less effective on the control currents in the absence of agonist (Fig. 6 , open symbols), with a small but detectable block at 10 PM (13.6 k 1.9%, mean f SEM, n = 5; compared to 4.4 f 1.4%, IZ = 5, at 1 PM). Effects of nifedipine at more depolarized holding potentials are difficult to examine because of slow inactivation and rundown, but qualitatively it appears to be more potent (Fig. 7 ). Nifedipine at 50-100 nM blocked -50% of the slow agonistinduced tail current in cells held continuously for several minutes at -50 mV in 3 of 3 cells, but recovery was incomplete. In most cells, it has been possible to detect an effect of 100 nM nifedipine on currents without Bay K 8644, when the N-current is selectively reduced by pretreatment with w-conotoxin (see Plummer et al., 1989) . In the cell shown in Figure 8 , 100 nM nifedipine blocked -50% of the current from a holding potential of -50 mV, but only -20% from -80 mV. The difference may be partially due to rundown, however, as a subsequent test at -50 mV produced little effect (Fig. 8A) . If any residual N-current is present, at least 50% of the L-current must have been blocked by 100 nM nifedipine from the holding potential of -50 mV. On average, 100 nM nifedipine blocked 36 + 7% (n = 4) of the total current remaining after w-conotoxin from a holding potential of -50 mV, and 13 + 3% (n = 7) from -80 mV. Most of the w-conotoxin-resistant current, from a holding potential of -80 mV, is also DHP-resistant (20 + 7% block by 10 PM nifedipine, n = 3). The current blocked by nifedipine shows no clear differences in activation kinetics from the control current (Fig. 8B) . (ZK) and a smaller effect on the sodium current. A different protocol (Fig. 9 B, C) demonstrates effects on 2 other potassium currents (Adams et al., 1982) , the transient outward current (IA) and the M-current (Z,). The rate of inactivation of Z, also appeared to be increased by nifedipine. These effects were concentration-dependent, as less block was observed at 1 PM nifedipine (Table 1) . Consistent with a nonspecific action of DHPs, the agonist (+)202-791 also reduced the amplitude of these 4 currents at 10 PM (Table 1 ). The effect of (+)202-79 1 was consistently slower than that of nifedipine and did not always reach a steady-state during the -5 min applications used, so its potency on sodium and potassium currents may be underestimated here.
Potassium and sodium currents Discussion
The evidence for nonspecific effects of DHPs on N-current (Figs. 2, 4) led us to investigate whether DHPs inhibit other voltagedependent currents. Figure 9A shows that 10 MM nifedipine has a substantial effect on the delayed rectifier potassium current
The DHP-sensitive current of frog sympathetic neurons is similar in sensitivity to both DHP agonists and antagonists to the DHP-sensitive (L-type) current of cardiac muscle. This supports the previous assumption that the relative DHP insensitivity of .__ "I:
The Journal of Neuroscience, July 1990, W (7) . This cell (e9830) had been pretreated with w-conotoxin for 10 min before recording was begun. The current amplitudes in w-conotoxin-pretreated cells were generally consistent with the previously reported -85% block of the total calcium current by w-conotoxin (Jones and Marks, 1989a) . A, Peak currents at -10 mV (Cl). The holding potential was changed from -50 to -80 mV at the times indicated. Zero time is the start of whole-cell recording. B, Records from the same experiment, taken before (left), during (middle), and after (right) the first response to nifedipine from -50 mV. The current blocked by nifedipine (difference current, calculated as the average of control and recovery records minus the current remaining in nifedipine) is shown below. The fast component of the tail currents is reduced by filtering (2 kHz).
neuronal calcium currents is due to the presence of qualitatively different currents rather than to a quantitatively lower potency on neuronal DHP-sensitive currents. DHP-sensitive calcium channels exist in frog sympathetic neurons but contribute little whole-cell current in the absence of DHP agonists, so the DHP-resistant N-current dominates. Most previous studies on neuronal calcium currents have used high (> 1 PM) concentrations of DHP agonists and antagonists, which raised the possibility that neuronal DHP-sensitive calcium channels were less sensitive to DHPs than are calcium channels in muscle (McCleskey et al., 1986; Taylor, 1988 ). That appears not to be the case. The EC,, of 50 nM for Bay K 8644 agrees well with values reported previously for cardiac muscle Figure 9 . Effects of nifedipine on potassium and sodium currents. Calcium and calcium-dependent currents were blocked by Mn2+ (see Materials and Methods). A, Inhibition of delayed rectifier and sodium currents. Brief (17 msec) depolarizations to + 10 mV from a holding potential of -50 mV evoke a rapid inward current followed by a slower outward current (inset). Three superimposed records are shown, taken before, during (dashed line) and after nifedipine, at the times marked by asterisks in the main figure. The records were digitally filtered at 6 kHz. The main figure shows the time course of the peak inward current (0) and the current at the end of the depolarization (A). Cell a9n 11. B, Inhibition ofl,. Voltage steps lasting 0.45 set were given from a holding potential of -30 mV. The main figure shows the "steady-state" currentvoltage relations measured at the end of each voltage step. Currents were not leak-subtracted and are given with respect to zero current. Inset shows currents recorded (left to right) before, during, and after 10 /IM nifedipine, upon voltage steps from -30 to -50 mV. The records were digitally filtered at 100 Hz. Cell a9n08. C, Inhibition of IA, from the same experiment as B. Following steps to voltages more negative than -50 mV, a transient outward current was observed upon return to -30 mV. The main figure shows the amplitude of the peak outward current at -30 mV, measured -10 msec after a 0.45 set step to the indicated voltage. This is effectively the steady-state inactivation curve for IA. The current measured after a step to -50 mV was defined as zero. Inset, Currents upon return to -30 mV from voltages between -50 and -100 mV, in 10 mV intervals. The currents were not leak subtracted and were digitally filtered at 200 Hz. The dashed line indicates zero current. The slowly activating outward current, most obvious after steps that generate little IA, is Zhl. Values arc means + SEM for 34 cells. The average of measurements taken before and after each drag application was used as the control value, to correct for rundown or drift in current amplitudes. I, was measured as the difference between currents at -30 mV following 0.45 set steps to -100 and -60 mV (see Fig. 90 . I, was measured as the leak-subtracted steady-state current at -30 mV. Z,, was measured as the peak inward current, and I, at 17 msec, for steps to 0 or + 10 mV, after leak subtraction (see Fig. 9A ). Separate experiments with saxitoxin and tetraethylammonium (not shown) indicate that the delayed rectifier activates with a 2-3 msec delay at these voltages, and the sodium current inactivates almost completely within 10 msec, so there should be little cross-contamination of the I,, and I, measurements. (Hess et al., 1984; Lacerda and Brown, 1989) and sensory neurons (Aosaki and Kasai, 1989) .
The potency of DHP antagonists is more difficult to evaluate due to the voltage or state dependence of DHP antagonist action (Bean, 1984; Bean et al., 1986) . Estimates of the dissociation constant of DHP antagonists for closed states of cardiac calcium channels range from 0.7 to 7 FM; at depolarized voltages, the EC,, is < 1 nM (Bean, 1984; Sanguinetti and Kass, 1984 ; see also Cohen and McCarthy, 1987, for GH, cells) . Resting block appears to be stronger (EC, , for calcium channels in smooth muscle (Bean et al., 1986; Yatani et al., 1987; Hering et al., 1988; McCarthy and Cohen, 1989; Nelson and Worley, 1989) . The EC,, of 300 nM for blockade of the Bay K 8644 effect by nifedipine, from a holding potential of -80 mV, is thus in the expected range. The EC,, measured in that way might be affected by interactions between nifedipine and Bay K 8644, and the effect could be in either direction. If DHP agonists and antagonists interact competitively, the potency of nifedipine would be underestimated (Nelson and Worley, 1989) . Alternatively, DHP agonists, by promoting the open state of the channel, could facilitate DHP antagonist binding. Cooperative interactions of DHP agonists and antagonists have sometimes been observed in binding studies (Kokubun et al., 1986) . Despite such uncertainties, it is clear that the action of nifedipine is qualitatively similar to its effect on L-type calcium currents of cardiac muscle.
As expected for action on an L-channel, nifedipine was more potent from a depolarized holding potential, -50 mV (Figs. 7, 8) . Rundown makes the EC,, difficult to estimate, but it is probably < 100 nM. DHP antagonists (Fig. 8 ) and agonists (data not shown) had larger fractional effects following pretreatment with o-conotoxin, as expected for a selective but incomplete blockade of N-current (Plummer et al., 1989) . Under conditions where the DHP antagonist effect was large, there was still no obvious difference between the activation kinetics of DHP-sensitive and DHP-resistant components of the calcium current (Fig. 8B) , consistent with the observation of tail currents well fit by a single-exponential process (Swandulla and Armstrong, 1988; Jones and Marks, 1989a) .
Two observations suggest that high concentrations of DHPs have a weak blocking action on the N-current. The stronger evidence is actually for DHP agonists (Fig. 2B) . The complex action of (+)202-791 on the peak current could have been explained as a mixture of agonist and antagonist properties on L-current, which has been observed even for "pure" agonist isomers (Kass, 1987) except that the 2 effects show differential rundown. The agonist effect (on peak current or on the slow tail currents) was relatively weaker after long periods of whole-cell recording. This can be most easily explained if the antagonist effect is on N-current, with N-current showing less rundown than L-current. If all of the effects of (+)202-79 1 are on L-current, the L-current remaining after long periods of dialysis must have selectively lost agonist sensitivity, which seems less plausible. It is more difficult to demonstrate a clear effect of DHP antagonists on N-current, but 10 PM nifedipine has a stronger blocking action on the control current than does 1 PM nifedipine (Figs. 4,6 ), despite nearly full block of the DHP agonist-induced current by 1 MM nifedipine. The simplest interpretation is that 10 PM nifedipine has a weak, nonspecific blocking action on N-current.
A slight blockade of N-current by micromolar concentrations of DHPs should not be surprising. At such concentrations, DHPs are known to have effects on other currents, including sodium (Yatani and Brown, 1985) , potassium (Nerbonne and Gurney, 1987) and T-type calcium (Akaike et al., 1989) currents. In fact, DHPs appear to block potassium currents more strongly than they block the N-current (Fig. 9, Table 1 ). The high lipid solubility of DHPs would produce extremely high concentrations in membranes, which could easily have nonselective effects. Clearly, effects of DHPs at micromolar concentrations must be interpreted with extreme caution. Aosaki and Kasai (1989) recently reported similar results for DHP actions on calcium currents of chick sensory neurons. However, they found no effect of nifedipine (up to 10 PM) on N-current. They also concluded that the w-conotoxin-resistant current was predominantly a DHP-sensitive L-current, even though it showed a slow (-10 set) inactivation process upon changes in holding potential. Inactivation at -40 mV has been considered a hallmark of N-current (Fox et al., 1987a) , but L-current in cardiac cells inactivates slowly and reversibly at a holding potential of -40 mV (Schouten and Morad, 1989) . For sympathetic neurons, Plummer et al. (1989) concluded that most of the w-conotoxin-resistant current was N-current. The current following w-conotoxin was clearly relatively enriched in L-current (Fig. 8) especially from relatively positive holding potentials, but most of the current from -80 mV was still DHPresistant.
It now seems indisputable that distinct L-and N-currents coexist in whole-cell recordings from sympathetic neurons. However, the N-current is kinetically different from that originally described in sensory neurons, and the contribution of L-current is quantitatively minor (Jones and Marks, 1989b; Plummer et al., 1989) . DHPs remain useful tools for separating L-and N-currents, but "side effects" and the voltage dependence of DHP action make this a nontrivial problem. In particular, it remains difficult to conclude that the contribution of L-current to the whole-cell current can be determined by blockade with a particular concentration of DHP antagonist.
